- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05266209
Comparison of Coconut and Sunflower Oil Application in Preserving Babies' Skin Integrity
Comparison of Coconut and Sunflower Oil Application in Preserving Skin Integrity of Infants in Neonatal Intensive Care Unit
Study Overview
Detailed Description
Although there is no consensus on the use of products in daily skin care to maintain the skin integrity of newborns, many products are used. These products; mustard, sunflower, sesame, coconut, olive, soybean, palm oils, ointment (Auqophor), cream (Eucerin) and moisturizers. It is stated that these products prevent skin drying and fissures, maintain skin integrity, and reduce transepidermal fluid loss (Vaseline).
Sunflower oil accelerates the maturation of the skin barrier, there is less weight loss in newborns younger than 35 weeks of gestation who are massaged with sunflower oil compared to the control group, the incidence of nosocomial infections in newborns who receive skin care with sunflower oil is lower than the control group, sunflower oil protects the newborn from infections, olive oil, more effective than oils such as soybean oil and mustard oil; In another study, it was determined that skin care applied to preterm newborns with sunflower oil reduced mortality by 26%, the duration of hospitalization was shorter in newborns treated with sunflower oil than the control group, and regular use of moisturizers had no effect on the incidence of infection. Recently, it has been reported that topical application of coconut oil is safe and feasible in very preterm infants and has beneficial effects on skin condition and recovery of infants. In a systematic review of randomized studies evaluating the effects of topical coconut oil in preterm infants, it was emphasized that in general, transepidermal fluid loss and infection rate were reduced in infants in the coconut oil group, the growth and skin integrity of the infants were better, and no significant side effects were experienced. In a study comparing coconut and carrot oils, it was stated that the skin flora and barrier function were better in babies using coconut oil.
Comparison of the application of Coconut and Sunflower Oil in the preservation of skin integrity, the amount of fluid ingested/extracted daily, and weight gain/decrease in infants hospitalized in the Neonatal Intensive Care Unit.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Adapazarı
-
Sakarya, Adapazarı, Turkey, 54050
- Sakarya Education and Training Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Voluntary verbal and written consent of the parents of the newborn,
- The gestational week of the newborn is 34 and above,
- The birth weight of the newborn is 2000 g and above,
- The hospitalization of the newborn is the first day of birth.
Exclusion Criteria:
- Unstable clinical condition and vital signs,
- Having a major congenital anomaly,
- High risk of infection due to surgery,
- More than 5% of the body surface is a skin disease,
- External application of medication to the skin in its treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental (coconut oil group)
Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Moisturizers are applied to the thorax, back, arms and legs by massage, respectively, and the skin is absorbed. If it is to be applied for the first time, it is applied to a small area of the body under the control of a doctor. If there is no reaction, it is applied by massaging other areas. Since the babies to be included in the sample group are borderline and moderately premature (34-37W), 3-4 ml/kg (coconut oil)moisturizer will be applied. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday). Routine care will be applied to the skin of the newborns in the control group in the hospital. The control group will be evaluated using the NSCE form 3 days a week (Monday, Thursday, Sunday). |
No special technique was used for sample selection, random sample selection will be made.
In the evaluation made according to the large effect size, the number of samples determined for Power: 0.80, :0.20 and :0.05 was determined as 66, with a minimum of 22 for each group.
Calculations were made in computer environment using Power analysis (G*Power 3.1.9.2) program.
Random selection method will be used while creating research groups.
Coconut oil, sunflower oil and control groups will be formed according to the order of admission to the unit.
E.g; Coconut oil is planned for the first hospitalized newborn, sunflower oil for the second newborn, and third hospitalized newborn control group.
This order will be repeated until a sufficient number of cases is reached when the newborns are included in the groups.
Other Names:
|
|
Other: Experimental (sunflower oil group)
Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Moisturizers are applied to the thorax, back, arms and legs by massage, respectively, and the skin is absorbed. If it is to be applied for the first time, it is applied to a small area of the body under the control of a doctor. If there is no reaction, it is applied by massaging other areas. Since the babies to be included in the sample group are borderline and moderately premature (34-37W), 3-4 ml/kg (sunflower oil) moisturizer will be applied. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday). |
No special technique was used for sample selection, random sample selection will be made.
In the evaluation made according to the large effect size, the number of samples determined for Power: 0.80, :0.20 and :0.05 was determined as 66, with a minimum of 22 for each group.
Calculations were made in computer environment using Power analysis (G*Power 3.1.9.2) program.
Random selection method will be used while creating research groups.
Coconut oil, sunflower oil and control groups will be formed according to the order of admission to the unit.
E.g; Coconut oil is planned for the first hospitalized newborn, sunflower oil for the second newborn, and third hospitalized newborn control group.
This order will be repeated until a sufficient number of cases is reached when the newborns are included in the groups.
Other Names:
|
|
No Intervention: No Intervention (Control group)
Before moistening, the skin of newborns is evaluated using the Newborn Skin Condition Evaluation Form form. Routine maintenance of the intensive care unit will be implemented. Evaluation with NSCE form: Evaluations will be made using the NSCE form 48-72 hours after each application (Monday, Thursday, Sunday). Routine care will be applied to the skin of the newborns in the control group in the hospital. The control group will be evaluated using the NSCE form 3 days a week (Monday, Thursday, Sunday) |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
effect on skin integrity
Time Frame: Evaluation with Newborn Skin Condition Evaluation Form (NSCE) form: Evaluations will be made using the YCDD form 48-72 hours after each application (Monday, Thursday, Sunday).
|
Evaluation with Newborn Skin Condition Evaluation Form (NSCE) form: Evaluations will be made using the YCDD form 48-72 hours after each application (Monday, Thursday, Sunday). Skin condition scoring of the newborn; It is performed according to the presence of signs of redness, dryness and deterioration of skin integrity/peeling. It was developed in a three-point Likert format and each item/finding is given a score from 1 to 3. The lowest score that can be obtained as a result of the evaluation is 3, and the highest score is 9. A total score higher than 3 indicates that there is a risk of deterioration of the skin integrity of the newborn, while a high score indicates that the newborn's skin condition is poor. |
Evaluation with Newborn Skin Condition Evaluation Form (NSCE) form: Evaluations will be made using the YCDD form 48-72 hours after each application (Monday, Thursday, Sunday).
|
|
the effect of the baby's weight gain/decrease on 7,14, 21, 28 days
Time Frame: The scale is sensitive enough to measure in very small units.
|
The baby's weight will be measured on days 7, 14, 21, 28, naked and without diapers.
|
The scale is sensitive enough to measure in very small units.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: NURSAN ÇINAR, Prof, Sakarya University
- Principal Investigator: HAMİDE ZENGİN, Asis Prof, Bilecik Seyh Edebali Universitesi
- Principal Investigator: İBRAHİM CANER, Prof, Sakarya University
- Principal Investigator: ERTUĞRUL GÜÇLÜ, Prof, Sakarya University
- Principal Investigator: ÖZNUR TİRYAKİ, PhD, Sakarya Education and Research Hospital
- Study Chair: MELTEM KARABAY, Asis Prof, Sakarya University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Other Grant/Funding Number: Community Foundation of Greater Birmingham Women's Breast Health Fund
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Care
-
Venus Research CenterEnrolling by invitationSkin Care | Pre and Post Procedure Skin CareEgypt
-
University of ArizonaNot yet recruitingGroup 1: Carrier Care (CC) Followed by Skin-to-Skin Care (SSC) Followed by Family Choice | Group 2: Skin-to-Skin Care (SSC) Followed by Carrier Care (CC) Followed by Family Choice
-
Eurofarma Laboratorios S.A.Not yet recruiting
-
Revision SkincareStephens & Associates, Inc.CompletedSkin Care | Photodamaged SkinUnited States
-
Power Life Sciences Inc.Not yet recruiting
-
Wayne State UniversityCompletedSkin CareUnited States
-
Eurofarma Laboratorios S.A.Completed
-
LycoRed Ltd.CompletedSkin CareUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
Clinical Trials on Coconut oil skin care group
-
Derince Training and Research HospitalOkan UniversityActive, not recruitingPremature Birth | Skin CareTurkey
-
University Hospital, LimogesNot yet recruitingGeriatrics | Oral Health CareFrance
-
University of ReadingUnknownDietary ModificationUnited Kingdom
-
Bournemouth UniversityDorset HealthCare University NHS Foundation TrustCompletedMetabolic Ketosis | Cognitive Impairments, MildUnited Kingdom
-
Université de SherbrookeCompleted
-
DeNova ResearchCompletedFacial Rejuvenation With Neurotoxins and/or Hyaluronic Acid FillersUnited States
-
University of Sao PauloEnrolling by invitation
-
Cornell UniversityCompletedDiet ModificationUnited States
-
Gadjah Mada UniversityUnknownCoronavirus InfectionsIndonesia
-
Oslo University HospitalUniversity of Oslo; Norwegian Institute of Public Health; Karolinska Institutet; Helsinki University Central Hospital and other collaboratorsActive, not recruitingObesity | Cardiovascular Disease | Asthma | Rhinitis, Allergic | Atopic Dermatitis | Food Allergy in Children | Non-communicable DiseasesNorway